Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

AbstractBackground. Immune checkpoint inhibitors targeting programmed cell death 1 (PD1) or its ligand (PD-L1) showed activity in several cancer types.Methods.

Saved in:

Bibliographic Details
Main Authors:	Bergmeister-Berghoff, Anna Sophie (Author) , Kiesel, Barbara (Author) , Widhalm, Georg (Author) , Rajky, Orsolya (Author) , Ricken, Gerda (Author) , Wöhrer, Adelheid (Author) , Dieckmann, Karin (Author) , Filipits, Martin (Author) , Brandstetter, Anita (Author) , Weller, Michael (Author) , Kurscheid, Sebastian (Author) , Hegi, Monika E. (Author) , Zielinski, Christoph C. (Author) , Marosi, Christine (Author) , Hainfellner, Johannes A. (Author) , Preusser, Matthias (Author) , Wick, Wolfgang (Author)
Format:	Article (Journal)
Language:	English
Published:	2015
In:	Neuro-Oncology Year: 2014, Volume: 17, Issue: 8, Pages: 1064-1075
ISSN:	1523-5866
DOI:	10.1093/neuonc/nou307
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/nou307 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/neuro-oncology/article/17/8/1064/2324867
Author Notes:	Anna Sophie Berghoff, Barbara Kiesel, Georg Widhalm, Orsolya Rajky, Gerda Ricken, Adelheid Wöhrer, Karin Dieckmann, Martin Filipits, Anita Brandstetter, Michael Weller, Sebastian Kurscheid, Monika E. Hegi, Christoph C. Zielinski, Christine Marosi, Johannes A. Hainfellner, Matthias Preusser, and Wolfgang Wick

Description
Summary:	AbstractBackground. Immune checkpoint inhibitors targeting programmed cell death 1 (PD1) or its ligand (PD-L1) showed activity in several cancer types.Methods.
Item Description:	Advance Access date 29 October 2014 Gesehen am 22.05.2020
Physical Description:	Online Resource
ISSN:	1523-5866
DOI:	10.1093/neuonc/nou307